Mechanisms of acute vasodilator response to bacterial lipopolysaccharide in the rat coronary microcirculation

British Journal of Pharmacology

Volumn 123, Issue 4, 1998, Pages 637-644

  Cannon, Toby R ^a   Mann, Giovanni E ^a   Baydoun, Anwar R ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bacterial lipopolysaccharide; Coronary microvasculature; Cyclooxygenase; Glucocorticoid; Lipocortin 1; Lipoxygenase; Nitric oxide; PLA2

Indexed keywords

BRADYKININ; BRADYKININ RECEPTOR; CYCLOHEXIMIDE; DEXAMETHASONE; DRUG DERIVATIVE; ENZYME INHIBITOR; ICATIBANT; LIPOCORTIN 1; LIPOPOLYSACCHARIDE; LIPOXYGENASE; N(G) NITROARGININE METHYL ESTER; PHOSPHOLIPASE A; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL; ARTICLE; CORONARY BLOOD VESSEL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; IN VITRO STUDY; MALE; MICROCIRCULATION; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; VASODILATATION;

ANIMALS; ANNEXIN A1; BRADYKININ; CORONARY VESSELS; CYCLOHEXIMIDE; DEXAMETHASONE; ENZYME INHIBITORS; LIPOPOLYSACCHARIDES; LIPOXYGENASE; MALE; MICROCIRCULATION; NG-NITROARGININE METHYL ESTER; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, BRADYKININ; VASODILATION;

EID: 0031990813     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701650     Document Type: Article

References (46)

1. G-monomethyl L-arginine causes nitric oxide synthesis in isolated arterial rings: Trouble in paradise. Biochem. Biophys. Res. Commun., 188, 590 - 596.
2. BAYDOUN, A.R., FOALE, R.D. & MANN, G.E. (1993). Bacterial endotoxin rapidly stimulates prolonged endothelium-dependent vasodilation in the rat isolated perfused heart. Br. J. Pharmacol., 109, 987 - 991.
3. BAYDOUN, A.R. & WOODWARD, B. (1991). Effects of bradykinin in the rat isolated perfused heart: role of kinin receptors and endothelium-derived relaxing factor. Br. J. Pharmacol., 103, 1829 - 1833.
4. BESSIN, P., BONNET, J., APFFEL, D., SOULARD, C., DESGROUX, L., PELAS, I. & BENVENISTE, J. (1983). Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. Eur. J. Pharmacol., 86, 403 - 413.
5. BROADLEY, K.J. (1979). The Langendorff heart preparation- reappraisal of its role us a research and teaching model for coronary vasoactive drugs. J. Pharmacol. Meth., 2, 143 - 156.
6. BURCH, R.M. (1990). Kinin signal transduction: Role of phosphoinositides and eicosanoids. J. Cardiovasc. Pharmacol., 15, S44 - S45.
7. CASALS-STENZEL, J., MUACEVIC, G. & WEBER, K. (1986). 2086, a new and specific antagonist of platelet activating factor (PAF) in vitro and in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 334, R44.
8. CHIBA, Y., MIKODA, N., KAWASAKI, H. & ITO, K. (1990). Endothelium-dependent relaxant action of platelet activating factor in the rat mesenteric artery. Naunyn-Schmiedeberg's Arch. Pharmacol., 341, 68 - 73.
9. COCKS, T.M. & ANGUS, J.A. (1991). Evidence that contraction of isolated arteries by L-NMMA and NOLA are not due to inhibition of basal EDRF release. J. Cardiovasc. Pharmacol., 17, S159 - S164.
10. CROXTALL, J.D. & FLOWER, R.J. (1992). Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc. Natl. Acad. Sci. U.S.A., 89, 3571 - 3575.
11. DOEBBER, T.W., WU, M.S., ROBBINS, J.C., CHOY, B.M., CHANG, M.N. & SHEN, T.Y. (1985). Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. Biochem. Biophys. Res. Commun., 127, 799 - 808.
12. DUNCAN, G.S., PEERS, S.H., CAREY, F., FORDER, R. & FLOWER, R.J. (1993). The local anti-inflammatory action of dexamethasone in the rat carrageenin oedema model is reversed by an antiserum to lipocortin 1. Br. J. Pharmacol., 108, 62 - 65.
13. FLEMING, I., DAMBACHER, T. & BUSSE, R. (1992). Endotheliumderived kinins account for the immediate response of endothelial cells to bacterial lipopolysaccharide. J. Cardiovasc. Pharmacol., 20 (suppl. 12), S135 - S138.
14. FLOWER, R.J. & ROTHWELL, N.J. (1994). Lipocortin-1: Cellular mechanisms and clinical relevance. Trends Pharmacol. Sci., 15, 71 - 76.
15. GERRITSEN, M.E., SCHWARZ, S.M. & MEDOW, M.S. (1991). Glucocorticoid-mediated alterations in fluidity of rabbit cardiac muscle microvessel endothelial cell membranes: influences on eicosanoid release. Biochim. Biophys. Acta, 1065, 63 - 68.
16. GILLARD, J., FORDHUTCHINSON, A.W., CHAN, C., CHARLESON, S., DENIS, D., FOSTER, A., FORTIN, R., LEGER, S., MCFARLAND, C.S., MORTON, H., PIECHUTA, H., RIENDEAU, D., ROUZER, C.A., ROKACH, J., YOUNG, R., MACINTYRE, D.E., PETERSON, L., BACH, T. & EIERMANN, G. (1989). L-663,536 (MK-886)(3-(1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl)-, 2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can. J. Physiol. Pharmacol., 67, 456 - 464.
17. HARPER, J.F. (1994). BASIC programme of a robust multiple comparison test for statistical analysis of all differences among group means. Comput. Biol. Med., 14, 437 - 444.
18. HECKER, M., BARA, A.T. & BUSSE, R. (1993). Relaxation of isolated coronary arteries by angiotensin-converting enzyme inhibitors: Role of endothelium-derived kinins. J. Vase. Res., 30, 257 - 262.
19. HECKER, M., BARA, A.T. & BUSSE, R. (1995). Angiotensinconverting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium. Eur. Heart J., 14 (suppl. 1), 161 - 163.
20. HU, W., KINNAIRD, A.A.A. & MAN, R.Y.K. 1991). Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart. Br. J. Pharmacol., 103, 1097 - 1102.
21. JONES, T.R., YOUNG, R., CHAMPION, E., CHARETTE, L., DENIS, D., FORD-HUTCHINSON, A.W., FRENETTE, R., GAUTHIER, J.Y., GUINDON, Y., KAKUSHIMA, M., MASSON, P., MCFARLANE, C., PIECHUTA, H., ROKACH, J., ZAMBOUI, R., DEHAVEN, R.N., MAYCOCK, A. & PONG, S.S. (1986). L-649,923, Sodium (betaS*,gammaR*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)- propylthio)-gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist. Can. J. Physiol. Pharmacol., 64, 1068 - 1075.
22. KATORI, M., MAJIMA, M., ODOI-ADOME, R., SUNAHARA, N., UCHIDA, Y. & ODOIADOME, R. (1989). Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in the anaesthetized rat. Br J. Pharmacol., 98, 1383 - 1391.
23. KAUFMAN, M., LETO, T. & LEVY, R. (1996). Translocation of annexin I to plasma membranes and phagosomes in human neutrophils upon stimulation with opsonized zymosan: Possible role in phagosome function. Biochem. J., 316, 35 - 42.
24. KELM, M. & SCHRADER, J. (1990). Nitric oxide release from isolated guinea-pig heart. Circ. Res., 66, 1561 - 1575.
25. G-methyl-1-arginine, an inhibitor of nitric oxide synthase. Biochem. Biophys. Res. Commun., 172, 1132 - 1138.
26. LANNI, C. & BECKER, E.L. (1985). Inhibition of neutrophil phospholipase A2 by p-bromophenylacyl bromide, nordihydro-guaiaretic acid 5,8,11,14-eicotetrayenoic acid and quercetin. Int. Anch. Allergy Appl. Immunol., 76, 214 - 217.
27. LEMBECK, F., GREISBACHER, T. ECKHART, M., HENKE, S., BREIPOHL, G. & KNOLLE, J. (1991). New, long-acting, potent bradykinin antagonists. Br. J. Pharmacol., 102, 207 - 304.
28. LILJA, I.A., DIMBERG, J., SJODAHL, R., TAGESSON, C. & GUSTAFSONSVARD, C. (1994). Effects of endotoxin and dexamethasone on group I and II phospholipase A2 in rat ileum and stomach. Gut, 35, 40 - 45.
29. MAN, R.Y.K., HU, W. & KINNAIRD, A.A.A. (1990). Coronary vascular response to platelet activating factor in the perfused rat heart. J. Lipid Mediat., 2, 75 - 83.
30. MENON, M.K., WOLF, A., ZEHETGRUBER, M. & BING, R.J. (1989). An improved chemiluminescence assay suggests non nitric oxide-mediated action of lysophosphatidylcholine and acetylcholine. Proc. Soc. Exp. Med. Biol., 191, 316 - 319.
31. MULDER, M.F., VAN LAMBALGEN, A.A., VAN KRAATS, A.A., SCHEFFER, P.C., BOUMANN, A.A., VAN DEN BOS, GC & THIJS, L.G. (1993). Systemic and regional hemodynamic changes during endotoxin or platelet-activating factor (PAF)-induced shock in rats. Circ. Shock, 41, 221 - 229.
32. 2+ signalling via platelet-activating factor receptor. FEBS Lett., 314, 125 - 129.
33. PETITCLERC. E., POUBELLE, P.E. & MARCEAU, F. (1994). Rapid protein synthesis and turnover is involved in interleukin-1-induced relaxation of the rabbit isolated mesenteric artery. Analysis of the arachidonate cascade. J. Pharmacol. Exp. Ther., 268, 1419 - 1425.
34. PERRETTI, M., AHLUWALIA, A., HARRIS, J.G., HARRIS, H.J., WHELLER, S.K. & FLOWER, R.J. (1996). Acute inflammatory response in the mouse: Exacerbation by immunoneutralization of lipocortin 1. Br. J. Pharmacol., 117, 1145 - 1154.
35. RADOMSKI, M.W., PALMER, R.M.J. & MONCADA, S. (1990). Glucocorticoids inhibit the expression of an inducible but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. U.S.A., 87, 10043 - 10047.
36. REDL, H., VOGL, C. & BAHRAMI, S. (1990). Effect of PAF antagonist BN 52021 in an ovine endotoxin shock. J. Lipid Mediat., 2, S195 - S202.
37. ROUZER, C.A., FORDHUTCHINSON, A.W., MORTON, H.E. & GILLARD, J.W. (1990). MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J. Biol. Chem., 265, 1436 - 1442.
38. ROYSTON, J.P. (1984). SPP - Statistical Package for Personal Computers. TCL., 40B Royal Hill, London, SE10 8RT. UK.
39. SLAPKE, J., SCHEWE, T., HUMMEL, S., WINKLER, J. & KOPF, M. (1983). Long strips from guinea pigs as test system for lipoxygenase inhibitors. Inhibition of arachidonic acid-induced contractions by 3-t-butyl-4-hydroyanisole and nordihydroguaiaretic acid. Biomed. Biochem. Acta, 42, 1309 - 1318.
40. SOLITO, E., NUTI, S. & PARENTE, L. (1994). Dexamethasone-induced translocation of lipocortin (annexin) 1 to the cell membrane of U- 937 cells. Br. J. Pharmacol. 112, 347 - 348.
41. SONG, W., FURMAN, B.L. & PARRATT, J.R. (1996). Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Eschericia coli endotoxin. Br. J. Pharmacol., 118, 2157 - 2163.
42. TAHRIJOUTI, M.A. & CHABY, R. (1990). Specific binding of lipopolysaccharides to mouse macrophages-I. Characteristics of the interaction and inefficiency of the polysaccharide region. Mol. Immunol., 27, 751 - 761.
43. TAYLOR, A.D., COWELL, A.M., FLOWER, R.J. & BUCKINGHAM, J.C. (1995). Dexamethasone suppresses the release of prolactin from the rat anterior pituitary gland by lipocortin 1 dependent and independent mechanisms. Neuroendocrinology, 62, 530 - 542.
44. THIEMERMANN, C. & VANE, J.R. (1990). Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol., 182, 591 - 595.
45. UENO, A., ISHIDA, H. & OHISHI, S. (1995). Comparative study of endotoxin-induced hypotension in kinnogen-deficient rats with that in normal rats. Br. J. Pharmacol., 114, 1250 - 1256.
46. WILSON, D.D., DE GARAVILLA, L., KUHN, W., TOGO, J., BURCH, R.M. & STERANKA, L.R. (1989). D-Arg-(Hyp3-D-Phe7)-bradykinin antagonist, reduces mortality in a rat model of endotoxic shock. Circ. Shock, 27, 93 - 101.